Kiora Pharmaceuticals KPRX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 2.78 | 22 | 0.12 | 0 | 0.09 | 30 |
| 2025Q2 | 2.88 | 22 | -9.39 | -2 | -6.52 | 32 |
| 2025Q1 | 3.01 | 24 | -8.87 | -2 | -6.22 | 34 |
| 2024Q4 | 3.30 | 26 | -15.14 | -4 | -11.27 | 36 |
| 2024Q3 | 3.66 | 30 | -10.81 | -3 | -8.61 | 39 |
| 2024Q2 | 4.20 | 33 | -6.53 | -2 | -5.34 | 41 |
| 2024Q1 | 6.35 | 35 | 65.60 | 13 | 47.92 | 42 |
| 2023Q4 | 4.70 | 6 | -31.93 | -2 | -15.33 | 14 |
| 2023Q3 | 5.11 | 8 | -53.00 | -6 | -32.21 | 16 |
| 2023Q2 | 5.79 | 14 | -21.97 | -3 | -14.36 | 20 |
| 2023Q1 | 30.06 | 10 | -17.33 | -2 | -10.62 | 17 |
| 2022Q4 | 30.87 | 11 | -22.78 | -2 | -13.75 | 19 |
| 2022Q3 | 55.35 | 11 | -53.09 | -5 | -30.91 | 18 |
| 2022Q2 | 169.42 | 9 | -23.99 | -2 | -14.51 | 15 |
| 2022Q1 | 224.06 | 11 | -27.60 | -4 | -18.88 | 18 |
| 2021Q4 | 543.60 | 15 | -38.73 | -6 | -27.10 | 20 |
| 2021Q3 | 17 | -24.91 | -3 | -15.89 | 25 | |
| 2021Q2 | 10 | -26.28 | -3 | -15.70 | 18 | |
| 2021Q1 | 13 | -26.22 | -3 | -14.43 | 21 | |
| 2020Q4 | 7 | -37.28 | -2 | -19.80 | 15 |